Overall survival in a NIH study using a modest conditioning regimen followed by hematologic stem cell transplantation in<unk>  deficient patients afflicted with immune deficiencies was 54% at 4 years;<unk>  deficient children transplanted for MDS with monosomy 7 experienced a 5-year survival of 68%.
GATA2 deficiency
WNT4 deficiency
Janus kinase 3 deficiency
ZC4H2 deficiency
CDK13-related disorder
LRBA deficiency
ZAP70 deficiency
1p36 deletion syndrome